| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 476,163 | 474,488 |
| Net change in cash, cash equivalents and restricted cash | -15,495 | -1,346 |
| Cash and cash equivalents at beginning of period | 290,111 | - |
| Cash and cash equivalents at end of period | 274,616 | - |
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)